Daily BriefsIndia

Daily Brief India: Swiggy, SK Finance Limited, Shoppers Stop, Dr. Reddy’s Laboratories and more

In today’s briefing:

  • Swiggy Pre-IPO Early Look – Innovation Leader, Profitability Laggard
  • SK Finance Pre-IPO Tearsheet
  • Earnings Playbook | Shoppers Stop (SHOP IN) | Target of Quadrupling Network
  • Dr. Reddy’s Laboratories (DRRD IN): Q4 Result- Sequentially Weak Quarter; Time to Book Profit


Swiggy Pre-IPO Early Look – Innovation Leader, Profitability Laggard

By Sumeet Singh

  • Swiggy aims to raise US$1.25bn in its upcoming India IPO. The company has filed confidentially for its IPO, which is likely to be launched towards the end of the year.
  • Swiggy, along with Zomato, operates a duopoly that has come to dominate the food delivery market in India. In 1H24, Swiggy serviced over 274,000 restaurants via its 370,000 delivery partners.
  • In this note, we will take an early look at the company based on the publicly available financials. 

SK Finance Pre-IPO Tearsheet

By Clarence Chu

  • SK Finance Limited (0893736D IN) is looking to raise US$260m in its upcoming India IPO. The bookrunners on the deal are Kotak, Jefferies, Motilal Oswal, and Nomura.
  • SK Finance is a non-deposit non-banking finance company middle layer (NBFC ML) operating in two main verticals, vehicle financing and financing for micro, small and medium enterprises (MSMEs).
  • As per the CRISIL report in the DRHP, the firm was the fastest growing player in the vehicle financing and MSME financing segments based on AUM growth over FY21-23.

Earnings Playbook | Shoppers Stop (SHOP IN) | Target of Quadrupling Network

By Pranav Bhavsar


Dr. Reddy’s Laboratories (DRRD IN): Q4 Result- Sequentially Weak Quarter; Time to Book Profit

By Tina Banerjee

  • Dr. Reddy’s Laboratories (DRRD IN) reported 13% revenue growth to INR71.1B in Q4FY24. EBITDA climbed 15% to INR18.7B, while net profit zoomed 36% to INR13.1B.
  • North America revenue grew 29% YoY to INR32.6B, driven by increase in volumes of base business, contribution from new launches, integration of Mayne portfolio, partly offset by price erosion.
  • After adjusting for brand divestment, revenue from India increased 11% YoY. Gross margin improved 140bps YoY and 10bps QoQ to 58.6%, due to better product mix and cost savings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars